Device Trial Radar · NCT07856446
ABVN Phase 2 - PENFS
Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Oct 8, 2021
Primary completion
Jun 9, 2022
Study completion Jun 9, 2022
Sponsor
- Lead sponsor
- Indiana UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Purdue University; National Institutes of Health (NIH)
- First posted
- Oct 2, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The vagus nerve is a nerve that controls many bodily functions, including stomach function. Investigators hope that electrically stimulating the nerve around the external ear will also stimulate the internal vagus nerve. If it does, then investigators hope that this may lead to additional treatment options for patients with nausea and vomiting and disordered stomach function. The overall purpose of the ABVN Phase 2 grant is to expand on previous work evaluating the effects of noninvasive stimulation on vagal nerve function. This will be accomplished through several independent, but related, studies. In this study, investigators will evaluate the effect of percutaneous electrical field stimulation on the vagus nerve in healthy subjects. \[This study was originally described in NCT06491758, however a separate record has been created to more accurately reflect the independence of the individual studies supported by the ABVN 2 grant.\]
Conditions
- Healthy Subjects
Interventions
Percutaneous Electrical Nerve Field Stimulation (PENFS)Device
The PENFS is a battery-operated micro-stimulation appliance weighing 5 grams designed as a disposable product for single use. It is placed behind the patient's ear and connected to stimulation needles on the auricle. The appliance transmits low-frequency electrical impulses.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with vagal nerve compound action potentials detectedTime frame: Day 1
- Change in amplitude of vagal nerve compound action potentialsTime frame: Day 1
- Number of participants with detectable changes in parasympathetic and sympathetic vagal nerve activityTime frame: Day 1
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Indiana University
Indianapolis, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.